Showing results (4161-4170 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 17, 2024
Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitisMeghana Moodabagil, Robert Easterling, Jing Peng, et al.
The Oncologist|June 12, 2024
National survey of patient perspectives on cost discussions among recipients of copay assistanceAnh B Lam, Ryan David Nipp, Jill S Hasler, et al.
The Oncologist|June 22, 2024
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gainsXiaolin Zhu, Emily Chan, Michelle L Turski, et al.
The Oncologist|June 10, 2024
Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case seriesJordyn Silverstein, Francis Wright, Dalila Stanfield, et al.
The Oncologist|May 31, 2024
Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year resultsZu-Guang Xia, Fang-Fang Lv, Qun-Ling Zhang, et al.
The Oncologist|June 1, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitorsFarshid Dayyani, Joseph Chao, Fa-Chyi Lee, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
The Oncologist|June 3, 2024
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevanceJonathan D Sorah, Allison M Deal, Sophia I Stein, et al.
The Oncologist|July 27, 2024
Immune-related encephalitis after immune checkpoint inhibitor therapyMonica W Buckley, Aanika Balaji Warner, Julie Brahmer, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Pageof 571